Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
V-Wave logo — Advancing the flow of life

V-Wave

Advancing the flow of life

Founded 2010 Israel Israel 68 employees Series C Total: $226.00M Biotechnology, Health Care +1

General Information

Company Name V-Wave
Founded Year 2010
Location Israel Israel
Founders / Decision Makers
Team member Team member
Employees 68
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with V-Wave. To contact V-Wave, visit vwavemedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does V-Wave compare?

A PDF of V-Wave and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting V-Wave soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About V-Wave

V-Wave is a privately held company headquartered in Israel, with a focus on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF). The company, founded in 2010, aims to address the significant impact of HF, which affects millions of people worldwide by providing solutions for patients who continue to experience disabling symptoms or require hospitalization even with optimized medical treatment. V-Wave's flagship product is a proprietary interatrial shunt designed to alleviate symptoms, decrease hospitalization rates, improve exercise capacity, and enhance overall quality of life for patients. The company's efforts stem from a talented team of engineers and medical scientists in Israel. Their senior management brings decades of experience in successfully developing, clinically testing, and bringing to market multiple implantable cardiovascular devices. In December 2021, V-Wave secured a significant $98.00M Series C investment from a diverse group of investors, including BRM Group, Pontifax, Pura Vida Investments, TriVentures, Aperture Venture Partners, Deerfield Management, Endeavour Vision, GHS Fund, Israeli Secondary Fund, Johnson & Johnson Innovation – JJDC, signifying the confidence of industry leaders in the company's mission and potential impact. V-Wave's commitment to addressing a critical unmet medical need in the healthcare and biotechnology sectors positions it as a promising venture for potential investors.

Business keywords: Cardiology, Heart Failure, Implantable Devices, Percutaneous Implantable Devices, Chronic Heart Failure, Interatrial Shunt, Clinical Testing, Quality of Life, Senior Management, Israel, United States, Medical Science, Hospitalization

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C V $98.00M 10
BRM Group Pontifax Pura Vida Investments
BRM Group, Pontifax +8
16 Dec 2021
Series C V $28.00M -
22 Sep 2020
Series C V $70.00M -
27 Apr 2018
Series B V $28.00M -
11 Jan 2016
Venture Round V $2.00M -
03 Jul 2013

V-Wave Alternatives & Competitors

View All Alternatives
V-Wave vs
Procyrion, Inc.
Procyrion, Inc. United States

Developing catheter-based circulatory support devices to address the needs of heart failure and kidn...

Series E
28 employees
Health Care, Medical Devices
V-Wave vs
Restore Medical
Restore Medical Israel

Revolution in Heart Failure

Grant
10 employees
Biotechnology, Health Care
V-Wave vs
Implicity
Implicity France

AI Cardiac Remote Monitoring

Venture round
128 employees
AI, Health Care
Compare V-Wave vs Implicity
Also compare with: V-Wave vs CorWave CorWave View all alternatives

FAQ About V-Wave

Advancing the flow of life
V-Wave was founded in 2010.
V-Wave is headquartered in Israel.
V-Wave operates in Biotechnology, Health Care and Medical Devices. Its work centres on Cardiology, Heart Failure, Implantable Devices and Percutaneous Implantable Devices.
V-Wave has approximately 68 employees.
V-Wave has completed 5 funding rounds, raising a total of $226.00M. The latest funding stage is Series C.
Top alternatives and competitors to V-Wave include Procyrion, Inc., Restore Medical, Implicity, CorWave, Cardiac Dimensions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
V-Wave and Procyrion, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for V-Wave, https://bouncewatch.com/company/v-wave, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes